10x Genomics
TXG
$41.25
Share price
-0.10%
Change (1 day)
-2.71%
Change (1 year)
Categories
10x Genomics (TXG) - Cash on Hand
Cash on Hand as of June 2023 : $0.39 B
According to 10x Genomics
's latest financial reports the company has $0.39 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
10x Genomics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.42 B | -26.8% |
| 2021-12-31 | $0.58 B | -11.48% |
| 2020-12-31 | $0.66 B | 56.45% |
| 2019-12-31 | $0.42 B | 551.76% |
| 2018-12-31 | $65.08 M | 35.99% |
| 2017-12-31 | $47.85 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $10.75 M | -97.25% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.15 B | -61.49% | 🇬🇧 UK |
 Novavax NVAX | $0.50 B | 29.26% | 🇺🇸 USA |
 Novocure
NVCR | $0.94 B | 140.38% | Jersey |